About this Class

If you’re a researcher, clinician, informaticist, commercial partner, or policy maker interested in cancer data science, register to attend this Cancer Data Exchange Summit.

You’ll have the opportunity to hear (and take part in) discussions around current opportunities and challenges with the following topics:

• How to use a patient’s data to determine their eligibility for clinical trials
• How to identify and develop data standards to detect immune-related adverse events
• Ways to enhance the efficiency and timeliness of the collection of cancer registry data
• Ways to support patient access, interoperability, and data sharing

You can also help identify cancer-specific elements; develop implementation guides; and define requirements to build large language models for extracting data.

The participant group will comprise researchers, clinicians, informatics/data scientists, patient advocates, standard-setting organizations (such as HL7/FHIR), policymakers, EHR vendors, and industry partners. Their collaborative efforts will focus on identifying current opportunities, challenges, and essential oncology-specific data requirements for the USCDI+ Cancer use cases (1) using real-world data to determine patient eligibility for clinical trials; (2) identifying immune-related adverse events; (3) enhancing the efficiency and timeliness of cancer registry data.